These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 33907880)
1. Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling. Zeng H; Zhao X; Tang C Cancer Chemother Pharmacol; 2021 Aug; 88(2):223-233. PubMed ID: 33907880 [TBL] [Abstract][Full Text] [Related]
2. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253 [TBL] [Abstract][Full Text] [Related]
4. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141. Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680 [TBL] [Abstract][Full Text] [Related]
5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. Namani A; Matiur Rahaman M; Chen M; Tang X BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329 [TBL] [Abstract][Full Text] [Related]
6. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177 [TBL] [Abstract][Full Text] [Related]
7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma. Huang CF; Zhang L; Ma SR; Zhao ZL; Wang WM; He KF; Zhao YF; Zhang WF; Liu B; Sun ZJ PLoS One; 2013; 8(12):e83479. PubMed ID: 24386210 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
10. Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway. Liu H; Xu X; Wu R; Bi L; Zhang C; Chen H; Yang Y Biomed Res Int; 2021; 2021():6616547. PubMed ID: 34212035 [TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
12. miR-185-5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9. Biswal P; Mallick B DNA Repair (Amst); 2024 Oct; 142():103750. PubMed ID: 39173500 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192 [TBL] [Abstract][Full Text] [Related]
14. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling. Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222 [TBL] [Abstract][Full Text] [Related]
15. miR-141-3p inhibits vascular smooth muscle cell proliferation and migration via regulating Keap1/Nrf2/HO-1 pathway. Zhang C; Kong X; Ma D IUBMB Life; 2020 Oct; 72(10):2167-2179. PubMed ID: 32897647 [TBL] [Abstract][Full Text] [Related]
16. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696 [TBL] [Abstract][Full Text] [Related]
17. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
18. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells. Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629 [TBL] [Abstract][Full Text] [Related]
19. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982 [TBL] [Abstract][Full Text] [Related]
20. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]